PharmaTher Holdings Ltd. (OTC:PHRRF – Get Free Report) shares were down 6.1% during trading on Friday . The company traded as low as $0.15 and last traded at $0.16. Approximately 178,931 shares were traded during mid-day trading, an increase of 5% from the average daily volume of 169,752 shares. The stock had previously closed at $0.17.
PharmaTher Price Performance
The stock has a 50 day moving average price of $0.15 and a 200 day moving average price of $0.16.
PharmaTher Company Profile
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury.
Recommended Stories
- Five stocks we like better than PharmaTher
- Pros And Cons Of Monthly Dividend Stocks
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- What is Insider Trading? What You Can Learn from Insider Trading
- MarketBeat Week in Review – 03/24 – 03/28
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
